Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$HENC Multi Day Runner Possibilities Here! +138% Friday!
$GTEH alert ~ Recent news announced the upcoming launch of the Company’s new line of Nespresso® compatible CBD-infused & non-CBD-infusedpremium coffeesinto the Company’s existing Secret Javasprogram.
Management notes that recently published research (via Fior Markets) sees the Global Coffee Pod and Capsule marketroughly doubling from 2017 to 2025, growing into a $29 billion total market over that period.
GenTech Enters $19bn Coffee Capsule Market with Nespresso® Compatible CBD-Infused Coffee Subscription Package
https://www.marketwatch.com/press-release/gentech-enters-19bn-coffee-capsule-market-with-nespressor-compatible-cbd-infused-coffee-subscription-package-2020-01-21
About GenTech Holdings, Inc.
GenTech Holdings, Inc. is a publicly traded company under the symbol GTEH. The company is creating a national chain of Hemp Centric Coffee Shop Retail Spaces where patrons can relax, drink CBD infused Teas and Coffees, try various own-brand products and experience holistic education and classes. The company is also building an extensive outreach program working with medical practitioners across the country in their own locations to educate their patients and increase awareness of the benefits of THC free CBD Products. All of this is offered under the brand 'The Healthy Leaf'
good news from $NAFS yesterday - https://finance.yahoo.com/news/voycare-enters-mou-incinta-medical-133000213.html
$NAFS Through its subsidiary company HTT & CTT Inc., Voycare continues to partner with some of the leading travel service providers in China including Ctrip, Tuniu and China International Travel Service, to create affordable and comprehensive travel packages for Chinese travelers coming to the Americas for medical treatment. With offices in Los Angeles and Shanghai and YOY growth in revenues from China outbound travel, Voycare and its subsidiary companies are poised to lead the way in medical tourism between Asia and the Americas.
$PBIO $2.58 set for another move up here, consolidation/weak hands done here imo.
https://finance.yahoo.com/news/pressure-biosciences-accelerating-rollout-proprietary-131500938.html
Pressure BioSciences Accelerating Rollout of Proprietary UST Platform for Water-Soluble CBD with Planned Release of Additional BaroShear Instrument
PR Newswire PR NewswireJanuary 30, 2020
Introduction of New Benchtop, R&D Scale, UST-Based "BaroShear Mini" in Q3 2020 Expected to Speed Market Penetration of PBI's UST Platform for Processing CBD and Other Oils into Stable, High Quality, Water-Soluble Nanoemulsions
New Instrument for Product Formulation and Development to Address Many Large and Diverse Markets
SOUTH EASTON, Mass., Jan. 30, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced that the Company plans to release a benchtop, R&D scale, Ultra Shear Technology™ ("UST™")-based BaroShear instrument to the market in the third quarter of 2020. The Company believes this new instrument will address a significant un-met need in product formulation and development laboratories in the cannabis, cosmetics, nutraceuticals, pharmaceuticals, and other large and diverse markets for processing CBD and other oils into stable, effectively water-soluble, highly absorbable nanoemulsions of oil in water.
CBD and other cannabinoids are extracted from the hemp plant in an oil form. The water-based biology of human bodies has difficulty accessing and absorbing oily molecules from the surface of ingested or topically applied hemp oil droplets. The ultra-low droplet sizes created by UST in nanoemulsions are designed to deliver levels of bioavailability and effectiveness that far exceed the dosing efficiencies achieved from today's macro or microemulsions of CBD Oil.
Kenneth F. Micciche, Director of PBI's UST Program, said: "We are very excited about the planned release later this year of the third instrument in the BaroShear product family. The aggressive marketing campaign we have underway for the pre-sale of our BaroShear K45 system and for the 2021 release of our industrial-scale BaroShear Max instrument has been well received by manufacturing laboratories. However, it has become apparent that product research and development labs prefer a smaller, bench-top, lower price-point, minimal throughput UST-based instrument. The BaroShear Mini clearly answers that need and will do so without cannibalizing sales to larger manufacturing facilities. We believe this new instrument will add significantly to PBI's revenue in 2020."
Richard T. Schumacher, President and CEO of PBI commented: "It has become apparent that Pressure BioSciences' breakthrough UST platform is a potential market-changing technology enabling a new generation of CBD and other cannabinoid products to more effectively meet consumer and supplier objectives. By delivering effective water solubility of cannabinoids, PBI's UST offers the promise of high absorption rates and bioavailability from ingestion or topical application of cannabinoid products. Most importantly, this delivers new confidence in controlled, safe and effective dosing for consumers. It also offers substantial cost reductions achieved as suppliers can eliminate the overloading of CBD and other cannabinoids into products, previously required to achieve targeted dosing levels."
Jeffrey N. Peterson, PBI Board Chairman, said: "Our innovation of the UST platform offers the potential to allow a universe of valuable materials that exist as oils (and thus do not naturally mix with water) to be delivered in effectively water-soluble preparations that can be easily absorbed by the water-based biology of humans and other animals, or applied in industrial and consumer applications, without requiring heavy use of undesirable chemical additives."
Mr. Peterson continued: "We believe that PBI will transform a vast range of applications with UST, that extend across multiple very large markets from dairy and other foods/beverages, to pharmaceuticals, nutraceuticals, and industrial applications. This is the technology platform that we believe will propel PBI into multi-billion dollar market opportunities, with resulting market value realization for our shareholders."
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired, patented technology from BaroFold, Inc. (the "BaroFold" technology) to allow entry into the bio-pharma contract services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology ("UST") platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.
Forward Looking Statements
This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "would," "expects," "plans," "intends," "anticipates," "believes," estimates," "predicts," "projects," "potential" or "continue" or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating these statements, you should specifically consider various factors. Actual events or results may differ materially. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2018, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.
For more information about PBI and this press release, please click on the following website link:
http://www.pressurebiosciences.com
Please visit us on Facebook, LinkedIn, and Twitter.
Cision
Cision
More
View original content:http://www.prnewswire.com/news-releases/pressure-biosciences-accelerating-rollout-of-proprietary-ust-platform-for-water-soluble-cbd-with-planned-release-of-additional-baroshear-instrument-300996081.html
SOURCE Pressure BioSciences, Inc
$NAFS Voycare is a California based medical tourism service provider helping overseas patients gain access to quality health care primarily in the fields of oncology, in vitro fertilization, cosmetic surgery and wellness. Voycare’s executive team has over 20 years of cross border tourism experience, specifically servicing Chinese outbound travelers to North and South America.
https://voycare.com/about-us/
$MCOA expands hempSMART brand, #CBD #vegas conference 11k attendees:
https://finance.yahoo.com/news/hempsmart-subsidiary-marijuana-company-america-180000077.html
hempSMART™, Subsidiary of Marijuana Company of America, Releases Global Sales and Marketing Strategy for 2020
PR Newswire PR NewswireFebruary 5, 2020
- hempSMART will participate in the International CBD Expo in Las Vegas. This is the kick-off of a year-long promotional tour to strengthen brand awareness and foster sales
- hempSMART is creating a new line of products branded "smart. - powered by hempSMART", as an expansion of the hempSMART™ label
- hempSMART develops a new look and feel to bolster brand recognition
ESCONDIDO, Calif., Feb. 5, 2020 /PRNewswire/ -- Marijuana Company of America, Inc. ("MCOA" or the "Company") (OTCQB: MCOA), an innovative hemp and cannabis corporation, is pleased to announce hempSMART's overview for global sales and marketing strategy for 2020.
Marijuana Company of America (PRNewsfoto/Marijuana Company of America)
Marijuana Company of America (PRNewsfoto/Marijuana Company of America)
More
Jesus Quintero, the Company's Principal Executive Officer and Chief Financial Officer, said, "hempSMART is focused on developing new marketing and distribution strategies that will help our Company grow. Our objective is to make our brand stronger and more competitive, and to open new channels of distribution both in the US and abroad."
HempSMART™ will participate in the USA CBD Conference in Las Vegas, February 12 -15, 2020 at the Las Vegas Convention Center. This is the Company's first participation in an industry trade show and it is the kick-off to initiate an international tour of industry-focused conferences, where hempSMART will connect with over 11,000 attendees in each regional city and position the hempSMART and smart. brands as strong industry leaders.
The new product line, branded as "smart. – powered by hempSMART" is directed at young, active consumers who are looking for high quality CBD to enhance their lifestyle and wellbeing. The smart. product line has created a fresh look at affordable prices that will differentiate us from the crowded marketplace.
Ms. Gloria Albarran Lynch, Global Marketing and Sales Manager will be leading the hempSMART marketing strategy, "With this new rebranding, our premium-quality hempSMART™ products will now be positioned to engage a larger audience of potential customers. With the strength of the CBD wellness and beauty markets that are expected to be worth as much as $25 billion globally in the next decade, we intend to take full advantage of this tremendous opportunity and take a leading position in this expanding market. HempSMART is focused on becoming a true power brand, backed by premium products that have been very well received by our customers. We will support this initiative with a solid marketing plan for the year that includes promotional activities across social media platforms and through sponsored events. At hempSMART we are really excited about the new products we are about to unveil under the umbrella of the new "smart." line. We are also reviewing and improving our classic product line, to ensure that we remain at the cutting edge of the industry. More details on these new products will be released in the near future."
HempSMART™ will join the CBD, Beauty, and Sales convention circuit across the country and into Mexico and UK. We are starting this new year with renewed strength, and we will continue to grow and expand, with new marketing and distribution strategies to support our growth. The trade show tour will give us increased exposure, brand positioning and sales expansion, while the network marketing group continues to grow.
Cision
Cision
More
View original content to download multimedia:http://www.prnewswire.com/news-releases/hempsmart--subsidiary-of-marijuana-company-of-america-releases-global-sales-and-marketing-strategy-for-2020-300999617.html
SOURCE Marijuana Company of America, Inc.
$IGEX http://sinister-cbd.com live. Product labels and graphics being finished by designers. We will have a good range of products to sell to consumers and wholesalers
https://twitter.com/_IGEX_/status/1225051021845549056
$NAFS Through its subsidiary company HTT & CTT Inc., Voycare continues to partner with some of the leading travel service providers in China including Ctrip, Tuniu and China International Travel Service, to create affordable and comprehensive travel packages for Chinese travelers coming to the Americas for medical treatment. With offices in Los Angeles and Shanghai and YOY growth in revenues from China outbound travel, Voycare and its subsidiary companies are poised to lead the way in medical tourism between Asia and the Americas.
$SKDI awesome news. Sun Kissed Industries Readies for Acquisition Closing with Significant Authorized Share Reduction
https://finance.yahoo.com/news/sun-kissed-industries-readies-acquisition-134500559.html
$ARSN Yuengling's decision to introduce a light ice cream is not new, though. As you can see in the following ad in a local newspaper from 1959. Yuengling's Ice Cream was just ahead of its time.
https://www.wsj.com/articles/PR-CO-20200130-909991
$EPAZ ~ Trader's Cheat Sheet >>
https://www.barchart.com/stocks/quotes/EPAZ/cheat-sheet
$KYNC - KYN Capital Group Inc. (“OTC: KYNC”) is an American multinational holding company headquartered in New York City, NY. Our main focus and goal is acquiring companies that excel in providing solutions in the categories of health, such as Algae World Inc., and wealth as in KYN Financial Group Inc.
$SKDI news. Sun Kissed Industries Buoyant as California State Assembly Bill 228 Looks to Pass CBD Foods Code
https://finance.yahoo.com/news/sun-kissed-industries-buoyant-california-140000196.html
$NAFS 150 Day Moving Average BUY 200 Day Moving Average BUY 100 - 200 Day MACD Oscillator BUY
$SKDI check out the article https://thefoxmagazine.com/technology/the-innovator-issue/
So exciting to be working with this guy, well done on this great article covering how you are taking this market by storm. Onwards and upwards for Products Group (Hakuna) and Sun Kissed Industries. CG. https://t.co/MgEhfpDTeD$skdi
— SFL Maven (@SFLMaven) January 31, 2020
$ARSN Exploring food brand asset opportunities,
existing or under-development.
Aureus is aware, active and astute in making the most of the possibilities.
$ARSN Exploring food brand asset opportunities,
existing or under-development.
Aureus is aware, active and astute in making the most of the possibilities.
$SKDI subbie put on watch now! thin, should go!
NAFS/Voycare Shares Financials with Shareholders Beginning with $4.3 Million in 2018 Fiscal Year-end
$NAFS - NAFS/Voycare Provides Corporate Update and 2020 Strategic Outlook
https://finance.yahoo.com/news/nafs-voycare-provides-corporate-2020-133000616.html
$KYNC has put out some big news recently!
https://www.otcmarkets.com/stock/KYNC/news
$SKDI ~ Research firm MRFR sees the global CBD market growing at better than 125% annually through 2026. Brightfield Group joins in this view, adding that 2019 alone will show over 900% expansion in total sales of CBD-based products across all related product groups. https://finance.yahoo.com/news/sun-kissed-industries-ceo-meet-140000531.html
$RXMD Progressive Care, Inc. (OTCQB: RXMD), through its subsidiary PharmCo, LLC, a South Florida health services organization and provider of administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, health practice risk management, prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), and the supply of prescription medications to long term care facilities.
UATG and UCIX about to merge? Something's developing
$NAFS COVINA, CA / ACCESSWIRE / January 23, 2020 / North America Frac Sand Inc. (OTC PINK:NAFS) (NAFS) ("NAFS" or the "Company"), also known as Voycare, a medical tourism service provider in California with combined revenues close to $10 million in the last 2 years through its subsidiary HTT & CTT Inc., and catering to a growing Chinese middle class of travelers coming to the U.S. on medical travel, is excited to share some the Company's upcoming corporate updates and 2020 strategic outlook.
$IQST #5G brings real #VR across distances and more, huge 2019 revs posted:
https://finance.yahoo.com/news/iqstel-inc-announces-swisslink-fy-103010595.html
iQSTEL, Inc. Announces Swisslink FY-2019 Revenue Of $5,610,633 for its First Year of Acquisition
GlobeNewswire GlobeNewswireJanuary 30, 2020
NEW YORK, NY, Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – iQSTEL, Inc. (IQST) announces that its 51% Swiss subsidiary generated over $5.6 million in revenue for 2019.
Mr. Iglesias, the Company’s CEO, stated: “The acquisition strategy we have set out for iQSTEL is showing early success. This vertical acquisition has been key since it gives us bare-bottom-cost-based voice routing interconnection into European cities and major carriers we did not previously have. Additionally, we have been able to quickly implement synergies in our admin, IT and operating departments. This acquisition and integration has been not only strategic in allowing us to provide cross-selling opportunities with Etelix, but more importantly, we believe it enhances our carrier network backbone, which we expect to be fundamental as we step up cross-selling opportunities with soon-to-be-announced services and acquisitions in other horizontal strategic solutions in the 5G, blockchain-based carrier payment, as well as DID portability space. Full-year revenue on an additive basis for both subsidiaries reached $21,938,503 for 2019. We expect organic growth in these 2 subsidiaries to be in the 20-30% YOY, but more importantly, will be the backbone of our transitioning into a full-service cloud-based 21st century communications provider in the near and mid-term.”
About iQSTEL Inc.:
iQSTEL (IQST) (www.iQSTEL.com) is a technology company offering a wide array of services to the Telecommunications Industry. These include services to International Long-Distance Telecommunications Operators (ILD Wholesale), Retail and Corporate markets (ILD Retail), Submarine Fiber Optic Network capacity, Satellite Communications services, Mobile Virtual Network Operator (MVNO) services, Internet of Things (IoT) technology solutions, Data Center facilities capacity leasing, and Blockchain solutions for the Telecommunications industry.
About Etelix.com USA, LLC:
Etelix.com USA LLC (www.etelix.com) is a wholly owned subsidiary of iQSTEL, Inc. Etelix.com USA, LLC is a Miami, Florida-based international telecom carrier founded in 2008 that provides telecom and technology solutions worldwide, with a commercial presence in North America, Latin America, and Europe. Enabled by its 214-license granted by the Federal Communications Commission (FCC), Etelix provides International Long-Distance voice services for Telecommunications Operators (ILD Wholesale), and Submarine Fiber Optic Network capacity for internet (4G and 5G). Etelix was founded in 2008 and has been profitable since inception.
About SwissLink Carrier AG:
SwissLink Carrier AG (www.swisslink-carrier.com) is a 51% owned subsidiary of iQSTEL, Inc. SwissLink Carrier AG is a Switzerland based international Telecommunications Carrier founded in 2015 providing international VoIP connectivity worldwide, with commercial presence in Europe, CIS and Latin America. SwissLink Carrier AG is a Swiss licensed Operator, having a domestic Interconnect with Swisscom, allowing their international Carrier Customers direct terminations via SwissLink into all Switzerland Fix & Mobile Networks. Since the takeover from Swissphone in November 2018 and the rename into SwissLink, they operate on a profitable level.
$PBIO #CBD water soluble news on new platform coming:
https://finance.yahoo.com/news/pressure-biosciences-accelerating-rollout-proprietary-131500938.html
Pressure BioSciences Accelerating Rollout of Proprietary UST Platform for Water-Soluble CBD with Planned Release of Additional BaroShear Instrument
PR Newswire PR NewswireJanuary 30, 2020
Introduction of New Benchtop, R&D Scale, UST-Based "BaroShear Mini" in Q3 2020 Expected to Speed Market Penetration of PBI's UST Platform for Processing CBD and Other Oils into Stable, High Quality, Water-Soluble Nanoemulsions
New Instrument for Product Formulation and Development to Address Many Large and Diverse Markets
SOUTH EASTON, Mass., Jan. 30, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced that the Company plans to release a benchtop, R&D scale, Ultra Shear Technology™ ("UST™")-based BaroShear instrument to the market in the third quarter of 2020. The Company believes this new instrument will address a significant un-met need in product formulation and development laboratories in the cannabis, cosmetics, nutraceuticals, pharmaceuticals, and other large and diverse markets for processing CBD and other oils into stable, effectively water-soluble, highly absorbable nanoemulsions of oil in water.
CBD and other cannabinoids are extracted from the hemp plant in an oil form. The water-based biology of human bodies has difficulty accessing and absorbing oily molecules from the surface of ingested or topically applied hemp oil droplets. The ultra-low droplet sizes created by UST in nanoemulsions are designed to deliver levels of bioavailability and effectiveness that far exceed the dosing efficiencies achieved from today's macro or microemulsions of CBD Oil.
Kenneth F. Micciche, Director of PBI's UST Program, said: "We are very excited about the planned release later this year of the third instrument in the BaroShear product family. The aggressive marketing campaign we have underway for the pre-sale of our BaroShear K45 system and for the 2021 release of our industrial-scale BaroShear Max instrument has been well received by manufacturing laboratories. However, it has become apparent that product research and development labs prefer a smaller, bench-top, lower price-point, minimal throughput UST-based instrument. The BaroShear Mini clearly answers that need and will do so without cannibalizing sales to larger manufacturing facilities. We believe this new instrument will add significantly to PBI's revenue in 2020."
Richard T. Schumacher, President and CEO of PBI commented: "It has become apparent that Pressure BioSciences' breakthrough UST platform is a potential market-changing technology enabling a new generation of CBD and other cannabinoid products to more effectively meet consumer and supplier objectives. By delivering effective water solubility of cannabinoids, PBI's UST offers the promise of high absorption rates and bioavailability from ingestion or topical application of cannabinoid products. Most importantly, this delivers new confidence in controlled, safe and effective dosing for consumers. It also offers substantial cost reductions achieved as suppliers can eliminate the overloading of CBD and other cannabinoids into products, previously required to achieve targeted dosing levels."
Jeffrey N. Peterson, PBI Board Chairman, said: "Our innovation of the UST platform offers the potential to allow a universe of valuable materials that exist as oils (and thus do not naturally mix with water) to be delivered in effectively water-soluble preparations that can be easily absorbed by the water-based biology of humans and other animals, or applied in industrial and consumer applications, without requiring heavy use of undesirable chemical additives."
Mr. Peterson continued: "We believe that PBI will transform a vast range of applications with UST, that extend across multiple very large markets from dairy and other foods/beverages, to pharmaceuticals, nutraceuticals, and industrial applications. This is the technology platform that we believe will propel PBI into multi-billion dollar market opportunities, with resulting market value realization for our shareholders."
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired, patented technology from BaroFold, Inc. (the "BaroFold" technology) to allow entry into the bio-pharma contract services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology ("UST") platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.
$IQST #5G telecom subsidiary almost $5M revs in 1st year:
https://finance.yahoo.com/news/iqstel-inc-announces-swisslink-fy-103010595.html
iQSTEL, Inc. Announces Swisslink FY-2019 Revenue Of $5,610,633 for its First Year of Acquisition
GlobeNewswire GlobeNewswireJanuary 30, 2020
NEW YORK, NY, Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – iQSTEL, Inc. (IQST) announces that its 51% Swiss subsidiary generated over $5.6 million in revenue for 2019.
Mr. Iglesias, the Company’s CEO, stated: “The acquisition strategy we have set out for iQSTEL is showing early success. This vertical acquisition has been key since it gives us bare-bottom-cost-based voice routing interconnection into European cities and major carriers we did not previously have. Additionally, we have been able to quickly implement synergies in our admin, IT and operating departments. This acquisition and integration has been not only strategic in allowing us to provide cross-selling opportunities with Etelix, but more importantly, we believe it enhances our carrier network backbone, which we expect to be fundamental as we step up cross-selling opportunities with soon-to-be-announced services and acquisitions in other horizontal strategic solutions in the 5G, blockchain-based carrier payment, as well as DID portability space. Full-year revenue on an additive basis for both subsidiaries reached $21,938,503 for 2019. We expect organic growth in these 2 subsidiaries to be in the 20-30% YOY, but more importantly, will be the backbone of our transitioning into a full-service cloud-based 21st century communications provider in the near and mid-term.”
About iQSTEL Inc.:
iQSTEL (IQST) (www.iQSTEL.com) is a technology company offering a wide array of services to the Telecommunications Industry. These include services to International Long-Distance Telecommunications Operators (ILD Wholesale), Retail and Corporate markets (ILD Retail), Submarine Fiber Optic Network capacity, Satellite Communications services, Mobile Virtual Network Operator (MVNO) services, Internet of Things (IoT) technology solutions, Data Center facilities capacity leasing, and Blockchain solutions for the Telecommunications industry.
About Etelix.com USA, LLC:
Etelix.com USA LLC (www.etelix.com) is a wholly owned subsidiary of iQSTEL, Inc. Etelix.com USA, LLC is a Miami, Florida-based international telecom carrier founded in 2008 that provides telecom and technology solutions worldwide, with a commercial presence in North America, Latin America, and Europe. Enabled by its 214-license granted by the Federal Communications Commission (FCC), Etelix provides International Long-Distance voice services for Telecommunications Operators (ILD Wholesale), and Submarine Fiber Optic Network capacity for internet (4G and 5G). Etelix was founded in 2008 and has been profitable since inception.
About SwissLink Carrier AG:
SwissLink Carrier AG (www.swisslink-carrier.com) is a 51% owned subsidiary of iQSTEL, Inc. SwissLink Carrier AG is a Switzerland based international Telecommunications Carrier founded in 2015 providing international VoIP connectivity worldwide, with commercial presence in Europe, CIS and Latin America. SwissLink Carrier AG is a Swiss licensed Operator, having a domestic Interconnect with Swisscom, allowing their international Carrier Customers direct terminations via SwissLink into all Switzerland Fix & Mobile Networks. Since the takeover from Swissphone in November 2018 and the rename into SwissLink, they operate on a profitable level.
Nio Inc. NIO 2019 Sanya S5 Round 6 Highlights https://vimeo.com/326040823
$RXMD is devoting further efforts to improve profitability and cash flow. Some of these efforts are already yielding beneficial results such as prioritizing specialized health and administrative services, securing new contracts with better payment terms, and promoting products with higher margins. The Company is also cutting costs in all departments which includes labor, consultants, advertising, and any area where the quality of service will not be sacrificed. The Company’s control shareholder has cut his salary and is also committed to cutting his contractual compensation. https://finance.yahoo.com/news/progressive-care-inc-releases-september-120005748.html
$NAFS Through its subsidiary company HTT & CTT Inc., Voycare continues to partner with some of the leading travel service providers in China including Ctrip, Tuniu and China International Travel Service, to create affordable and comprehensive travel packages for Chinese travelers coming to the Americas for medical treatment. With offices in Los Angeles and Shanghai and YOY growth in revenues from China outbound travel, Voycare and its subsidiary companies are poised to lead the way in medical tourism between Asia and the Americas.
$SKDI has put out some big news recently!
https://www.otcmarkets.com/stock/SKDI/news
$TWOH is on watch fro rebound
https://finance.yahoo.com/quote/TWOH?p=TWOH&.tsrc=fin-srch
$SKDI Better CBD Isolate standards aren’t something we invented, its a minimum basic standard here in Maine. We want people of the entire world to benefit from our company practices while challenging and encouraging the industry to walk with us towards ouor goals. Not just better standards industry wide, but also better understanding for the consumer of how CBD can help you and how to wade through a market of little transparency.
$SKDI ~ Purity of our CBD Isolate is our top priority. People deserve 99.9% when they are promised a THC free Isolate. From us, that’s what you’ll get. When someone orders distillate for edibles or topicals as a full spectrum medicine, we want the caregiver and their patient to know and trust what they are getting is in it’s purest form. No residual solvent. No impurities. We’ll show you how we get to there with complete transparency, so that there’s never any question about what you’re buying from us, or anyone else, ever again. Full Spectrum, Broad Spectrum, and Isolated Spectrum, We’ve got the Whole Spectrum in mind! http://www.sunkissedindustries.com
$EDXC interview at NASDAQ site next week, news:
https://finance.yahoo.com/news/cbd-unlimited-invited-exclusive-interview-103010554.html
CBD Unlimited Invited for Exclusive Interview at Nasdaq Market Site in Times Square
GlobeNewswire GlobeNewswireJanuary 29, 2020
CAVE CREEK, AZ, Jan. 29, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CBD Unlimited, Inc. (EDXC), formerly known as Endexx Corporation, a provider of innovative phytonutrient-based food and nutritional products, is pleased to announce the Company has been invited for an exclusive interview taking place at the Nasdaq MarketSite in Times Square, New York City on Wednesday, February 5th, 2020.
Mr. Todd Davis, CBD Unlimited’s Chairman and CEO, will be addressing the Company’s recent business developments and rapid growth of the CBD market. Once recorded, the interview will be released and immediately accessible to the public. This interview comes quickly after the Company’s new product suite launch and announcements of news related to additional international markets.
“We are thrilled to have the opportunity to share our recent developments and outlook for 2020 at the Nasdaq MarketSite in New York City,” commented Todd Davis, CEO and Chairman of CBD Unlimited. “2019 proved to be a tremendous year for our Company and we look forward to updating our audience on several new initiatives. Our team continues to cohesively exceed expectations while innovating new products and delivering to our customers. We look forward to sharing our updates directly from one of the top exchanges in the world right in the heart of New York City.”
About CBD Unlimited, Inc.
CBD Unlimited, Inc. develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.3% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of research and experiments in order to protect the accuracy in dosage and delivery of absorption per each serving.
In the interest of providing conformity with federal and state mandates, the company has incorporated the “Gorilla-Tek” platform into its business practices. The Gorilla-Tek platform is the first standardized hardware agnostic and software solution that tracks high-risk, high-shrink regulated, and restricted products maintained under federal/state/local compliance. The platform provides asset protection, inventory management, compliance and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the integrated “Gorilla-Tek” platform is tremendously efficient as it provides up-to-the-minute accounting and product details. Gorilla-Tek increases productivity, while reducing costs for retailers and costs in time for customers.
Website: www.cbdunlimited.com
Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.
Contact:
For further investor and media information, contact:
CBD Unlimited, Inc.
Todd Davis
Chairman & CEO
Todd@cbdunlimited.com
480-595-6900
$ARSN Adds Three Industry Veterans to its Advisory Board https://finance.yahoo.com/…/aureus-inc-adds-three-industry-…
$TWOH Latest update! https://finance.yahoo.com/news/two-hands-corporation-set-launch-210000504.html
$TWOH is on Facebook, mark their page! https://www.facebook.com/twohandscorp/
$NAFS ~ Outbound medical travel from China has seen rapid growth in the last two years. According to the International Medical Travel Journal and a report from Global Growth Markets it is estimated there were 500,000 outbound Chinese medical travelers spending at least $10 billion in 2018, with the numbers expected to reach $30 billion in spending by 2021 according to Statista Research. https://finance.yahoo.com/news/nafs-voycare-provides-corporate-2020-133000616.html
$EPAZ Cannabis Market Showing Growing Interest in Proprietary Bitcoin Payment Solutions
$EPAZ Cannabis Market Shows Growing Interest in Proprietary Bitcoin Payment Solutions -https://t.co/CBHMgxX5kZ $FB, $WEED, $TLRY, $TCNNF, $ACB, $CLSH, $OSTK, $HEMP, #potstocks, #hemp, #pennystocks, #bitcoin, #drones, #dronesnews, #blockchain, #stocks
— Epazz, Inc. Ticker: $EPAZ (@epazz) November 15, 2019
$ICNB is also supplying restaurant chains like Hooters with well liquors: tequila, gin, vodka, rum, etc. What goes well with Hooters? NASCAR. There’s a cross promotional deal with NASCAR to draw eyeballs to these “private label” brands.
$PBIO near sellout of water-soluble CBD oil system:
https://finance.yahoo.com/news/pressure-biosciences-announces-significant-order-131500666.html
Pressure BioSciences Announces Significant New Order and Near Sellout on Revolutionary Nanoemulsification System for Water-Soluble CBD Oil
PR Newswire PR NewswireJanuary 24, 2020
New Order for Six BaroShear K45 Systems Brings Total to Nine Orders Received for Company's New Ultra Shear Technology™ Based Platform. Additional Orders Expected Shortly Would Sell Out Planned Initial Build of 12 Systems, with Approximate Total Value of $2.4 Million.
SOUTH EASTON, Mass., Jan. 24, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced that the Company has received a purchase order from a new customer for six (6) proprietary Ultra Shear Technology™ ("UST™")-based nanoemulsification systems for processing CBD Oil into stable, effectively water-soluble, highly absorbable nanoemulsions of oil in water. Such nanoemulsions are expected to exhibit levels of bioavailability that far exceed the bioavailability of today's macro or microemulsions of CBD Oil.
CBD is extracted from the hemp plant in an oil. As with any oil-based product, it is difficult for the water-based biology of the human body to access and absorb CBD molecules from relatively large hemp oil drops. This poor and variable absorption of CBD results in low and variable bioavailability of the CBD molecule in the body. Low or widely varying levels of absorption and bioavailability of CBD adversely impacts the effective delivery of the potential benefits of many CBD products on the market today.
The purchase order for six BaroShear K45 systems was placed by Mr. Jason Ellis, President of Vegas CBD Factory. When asked about his order, Mr. Ellis commented: "As consumers rush to try, use and adopt CBD-infused products, it is important to realize that the CBD in the product should be in a high-quality, water-soluble and reliably dosed form. Proper dosing levels with high bioavailability of CBD from ingested products will in turn increase the chance for the consumer to achieve and optimize the potential beneficial effects of the CBD."
Mr. Ellis continued: "Understanding and addressing this issue is a pivotal challenge for the CBD industry. At Vegas CBD Factory, we have spent a significant amount of time searching for the best method available to make high-quality nanoemulsions of CBD oil. We have concluded that PBI's proprietary UST-based platform is the best technology available for achieving optimized dosing and have concluded that to give our customers the best CBD-based product, we should be processing our material using the BaroShear K45 nanoemulsification platform. Consequently, we have placed an initial order for six K45 systems."
Kenneth F. Micciche, Director of PBI's UST Program, said: "Recent BaroShear K45 instrument development efforts and demonstrations have propelled a refreshed sales effort for this innovative instrument system since the beginning of 2020. In the first three weeks of this new marketing initiative, we have secured an order for six BaroShear K45 systems and have genuine interest in additional purchases for many more units. We are excited and inspired to see our aggressive new marketing efforts for the BaroShear K45 taking such a strong early hold, and we anticipate further significant orders in the days and weeks ahead."
Richard T. Schumacher, President and CEO of PBI, commented: "In addition to the new order for six BaroShear K45 systems, there are numerous additional groups who have shown high levels of interest in acquiring the new BaroShear K45 nanoemulsification system. Our team is diligently following up with these interested parties; we believe that several of these groups will be placing purchase orders with us in the very near future. These are very exciting times for all PBI stakeholders."
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired, patented technology from BaroFold, Inc. (the "BaroFold" technology) to allow entry into the bio-pharma contract services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology ("UST") platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.
$EXDC #CBD highlighted in Cannabis Industry Security Investment News http://www.stockmarketpress.com/cannabis-industry-security-investment-news/
DISCLAIMER:
Opinions expressed on this board and emails are just that. Opinions. I am not a licensed broker. Trading strategies discussed on this board are often high risk and not suitable everyone. If you are losing money in the market, you may wish to seek the advice of a licensed securities professional.
No one is responsible for your gains or losses in the market except YOU. If you follow stocks, strategies discussed on this board, you may LOSE ALL YOUR MONEY. Please weigh the strategies discussed here carefully against what you are willing to risk.
Please do your own due diligence before buying or selling ANY SECURITY in the open market, there are no guarantees.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |